Prof. Philip Tofilon Moffitt Cancer Center and Research Institute, USA

Phil Tofilon has been a Professor/Member at the H. Lee Moffitt Cancer Center in the Drug Discovery Department since 2006. Prior to this appointment he was Chief of the Molecular Radiation Therapeutics Branch at the National Cancer Institute. His research is aimed at defining the fundamental determinants of cellular radiosensitivity... read morewith the ultimate goal of developing more effective strategies for tumor radiosensitization. Over the last few years his studies have focused on the role of induced gene expression as well as the microenvironment in regulating tumor cell radiosensitivity.